JEMPERLI Approved in EU for Endometrial Cancer

According to MarketScreener, patients with endometrial cancer in Europe now have a new treatment option. Recently, the European Commission (EC) granted conditional marketing authorization to GlaxoSmithKline for their therapy JEMPERLI…

Continue Reading JEMPERLI Approved in EU for Endometrial Cancer

Could PARP Inhibitors Treat Pancreatic Cancer?

Recently, scientists have been exploring a more genetically-based underlying cause of pancreatic cancer. Now, according to Medical XPress, researchers are deepening their understanding of genetics and pancreatic cancer in relation…

Continue Reading Could PARP Inhibitors Treat Pancreatic Cancer?